| 751 | CNTBConnect Biopharma Holdings Ltd |
64 mil US$ |
-86.687,5% |
2025 |
| 752 | AVTXAvalo Therapeutics, Inc. |
59 mil US$ |
-132.642,4% |
2025 |
| 753 | HCWBHCW Biologics Inc. |
54,2 mil US$ |
-14.677,1% |
2025 |
| 754 | INMBInmune Bio, Inc. |
50 mil US$ |
-91.866,0% |
2025 |
| 755 | ENTXEntera Bio Ltd. |
42 mil US$ |
-27.235,7% |
2025 |
| 756 | KZIAKazia Therapeutics Ltd |
42 mil AUD |
-49.290,5% |
2025 |
| 757 | ALTAltimmune, Inc. |
41 mil US$ |
-214.861,0% |
2025 |
| 758 | NTHINeonc Technologies Holdings, Inc. |
40 mil US$ |
-155.404,4% |
2025 |
| 759 | AXIMAxim Biotechnologies, Inc. |
39,5 mil US$ |
-20.395,0% |
2023 |
| 760 | CUPRCuprina Holdings (Cayman) LTD |
38,8 mil US$ |
-9366,7% |
2025 |
| 761 | GRDXGridAI Technologies Corp. |
36,3 mil US$ |
-17.634,4% |
2025 |
| 762 | LYELLyell Immunopharma, Inc. |
36 mil US$ |
-762.355,6% |
2025 |
| 763 | IBOImpact Biomedical Inc. |
32 mil US$ |
-36.993,8% |
2025 |
| 764 | IFRXInflaRx N.V. |
29,3 mil € |
-155.582,1% |
2025 |
| 765 | TLPHTalphera, Inc. |
28 mil US$ |
-51.035,7% |
2025 |
| 766 | CKDXFOpthea Ltd |
25 mil US$ |
-651.164,0% |
2025 |
| 767 | SNTISenti Biosciences Holdings, Inc. |
22 mil US$ |
-279.263,6% |
2025 |
| 768 | JUNSJupiter Neurosciences, Inc. |
21,8 mil US$ |
-39.662,8% |
2025 |
| 769 | SKVISkinvisible, Inc. |
20 mil US$ |
-5320,2% |
2025 |
| 770 | BDPTBioadaptives, Inc. |
18,3 mil US$ |
-8523,4% |
2025 |
| 771 | PRFXPRF Technologies Ltd. |
17 mil US$ |
-29.541,2% |
2025 |
| 772 | CDIOCardio Diagnostics Holdings, Inc. |
14,8 mil US$ |
-43.832,5% |
2025 |
| 773 | YBGJYubo International Biotech Ltd |
12,4 mil US$ |
-8736,7% |
2025 |
| 774 | GNLXGENELUX Corp |
8 mil US$ |
-401.812,5% |
2025 |
| 775 | KAYSKaya Holdings, Inc. |
7,1 mil US$ |
-29.168,2% |
2024 |
| 776 | VRAXVirax Biolabs Group Ltd |
6,3 mil US$ |
-95.739,2% |
2025 |
| 777 | ASBPAspire Biopharma Holdings, Inc. |
6,2 mil US$ |
-394.725,1% |
2025 |
| 778 | CELZCreative Medical Technology Holdings, Inc. |
6 mil US$ |
-99.916,8% |
2025 |
| 779 | TCRTAlaunos Therapeutics, Inc. |
5 mil US$ |
-83.520,0% |
2025 |
| 780 | OWPCOne World Products, Inc. |
4,9 mil US$ |
-80.917,4% |
2024 |
| 781 | HSCSHeartSciences Inc. |
4,3 mil US$ |
-211.666,5% |
2026 |
| 782 | ADTXAditxt, Inc. |
3,2 mil US$ |
-1.349.028,2% |
2025 |
| 783 | AIBTAibotics, Inc. |
2,2 mil US$ |
-101.500,3% |
2025 |
| 784 | RVMDRevolution Medicines, Inc. |
0 US$ |
n. d. |
2025 |
| 785 | PRAXPraxis Precision Medicines, Inc. |
0 US$ |
n. d. |
2025 |
| 786 | SYRESpyre Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 787 | SRRKScholar Rock Holding Corp |
0 US$ |
n. d. |
2025 |
| 788 | VKTXViking Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 789 | DNLIDenali Therapeutics Inc. |
0 US$ |
n. d. |
2025 |
| 790 | AMLXAmylyx Pharmaceuticals, Inc. |
0 US$ |
n. d. |
2025 |
| 791 | DSGNDesign Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 792 | MNPRMonopar Therapeutics |
0 US$ |
n. d. |
2025 |
| 793 | NGNENeurogene Inc. |
0 US$ |
n. d. |
2025 |
| 794 | ALLOAllogene Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 795 | ARTVArtiva Biotherapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 796 | EPRXEupraxia Pharmaceuticals Inc. |
0 US$ |
n. d. |
2025 |
| 797 | CAPRCapricor Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 798 | CMPXCompass Therapeutics, Inc. |
0 US$ |
n. d. |
2025 |
| 799 | PALIPalisade Bio, Inc. |
0 US$ |
n. d. |
2025 |
| 800 | RCKTRocket Pharmaceuticals, Inc. |
0 US$ |
n. d. |
2025 |